Brian Rosa
Surgical · St Petersburg, FLNPI 1487034427
Payments from drug & device makers
Across 141 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$780
- GSK$731
- Lilly USA, LLC$399
- Novo Nordisk$209
- Bayer$158
- Novartis$105
- plus $603 from 16 others
What the payments were for
- Food & beverage$2,985100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $780 |
| GSK | 30 | $731 |
| Lilly USA, LLC | 18 | $399 |
| Novo Nordisk | 12 | $209 |
| Bayer | 7 | $158 |
| Novartis | 7 | $105 |
| Dexcom, Inc. | 6 | $98 |
| Pfizer | 6 | $96 |
| Boehringer Ingelheim | 4 | $95 |
| Johnson & Johnson | 2 | $34 |
| Amgen | 2 | $33 |
| Alkermes, Inc. | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Insmed, Inc. | 1 | $27 |
| Mylan Specialty L.p. | 1 | $25 |
| Si-bone, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific | 1 | $20 |
| Inogen, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Lucid Diagnostics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$226
- TRELEGY ELLIPTA$125
How this compares
$2,985 in reported general payments places this provider in the 85th percentile of 1,018 surgical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $50,559 |
| EliquisApixaban | 32 | $36,905 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $32,912 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 43 | $30,289 |
| TrulicityDulaglutide | 25 | $25,246 |
| FarxigaDapagliflozin Propanediol | 28 | $22,186 |
| Celecoxib | 102 | $20,929 |
| EntrestoSacubitril/Valsartan | 20 | $16,909 |
| JardianceEmpagliflozin | 20 | $16,153 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $13,334 |
| MultaqDronedarone Hcl | 12 | $9,172 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 53 | $8,997 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 83 | $7,774 |
| Gabapentin | 223 | $5,715 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,398 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $780 | $55,87385 claims |
| Novo NordiskOzempic | $209 | $50,55952 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $731 | $46,24651 claims |
| PfizerEliquis | $96 | $36,90532 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $399 | $26,42974 claims |
| NovartisEntresto | $105 | $16,90920 claims |
| Boehringer IngelheimJardiance | $95 | $16,15320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,018 surgical providers in Florida.
Other surgical in St Petersburg
- Jessica McCarrySt Petersburg$445K
- Salvatore ArmeniaSt Petersburg$6K
- Lauren ScurrySt Petersburg$5K
- Aaron SookhooBrandon$742K
- Harmony ChurchTallahassee$265K
- Matthew HammondPensacola$155K
- Pamela LiggettMiami$120K
- Stephanie CarrollPalm Beach Gardens$114K
- Christina NauglePalm Beach Gardens$96K
- Kathleen McMichaelClearwater$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.